Axovant is founded and financed by Roivant and its CEO Vivek Ramaswamy, whose central strategy is to buy drugs that have been abandoned or shelved by big pharma and successfully bring them to market.

Elon Musk, a key megadonor in the 2024 election, has apparently decided he can’t risk being away from President-elect Donald ...

If you believe that, then democracy was voted out across the G7 nations. In the United States, the Democratic coalition ...

formerly known as Axovant and one of the 'vant' companies originally founded by entrepreneur Vivek Ramaswamy. Sio's board of directors has decided it is time to call it quits and abandon the ...

Entrepreneur-turned-politician and former Republican presidential candidate Vivek Ramaswamy has been a robust ... on fiat currency.” See Also: ‘Pharma Bro’ Martin Shkreli Predicts ...

Strive Asset Management, co-founded by Trump ally Vivek Ramaswamy, plans to launch a bitcoin bond ETF. Read more.

An icon in the shape of a lightning bolt. Impact Link Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

Part of America's strength lies in entrepreneurial risk-taking and a culture that fosters it. Think SpaceX, Apple or Netflix.

Bitcoin hits $100K on broad market upswing, with altcoins also seeing gains. MicroStrategy buys $101M worth of BTC.